Clinical Trial Results:
            The Einstein CYP cohort study. Oral direct factor Xa inhibitor rivaroxaban in patients with acute symptomatic deep-vein thrombosis or pulmonary embolism using a strong CYP 3A4 inducer.
    
|     Summary | |
|     EudraCT number | 2008-003303-31 | 
|     Trial protocol | NL DE HU AT IT | 
|     Global completion date | 
                                    26 Jun 2011
                             | 
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | 
                                        No
                                 | 
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Results information | |
|     Results version number | v1(current) | 
|     This version publication date | 
                                    12 Jul 2016
                             | 
|     First version publication date | 
                                    30 Oct 2014
                             | 
|     Other versions | |
|     Summary report(s) | Bayer Study Synopsis | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
